| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |